Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-016850
Filing Date
2016-03-29
Accepted
2016-03-29 19:08:52
Documents
1
Period of Report
2016-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7829
  Complete submission text file 0000899243-16-016850.txt   9300
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SERES HEALTH, INC. 161 FIRST STREET CAMBRIDGE MA 02472
Business Address
Shaff Eric D. (Reporting) CIK: 0001643734 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 161536686